Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Streptokinase therapy for deep vein thrombosis: A comprehensive review of the english literature
1990
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: A European multicenter double-blind trial
1992
Thrombolysis for pulmonary embolism
1991
Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis
1994
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Low-molecular-weight Heparins for the Treatment of Venous Thromboembolism
1993
PHLECO: a multicenter study of the fate of 1647 hospital patients treated conservatively without fibrinolysis and surgery
1993
Prevention of VTE in Orthopedic Surgery Patients
2012 Standout
Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis
2014
Perioperative Management of Antithrombotic Therapy
2012 Standout
Embolic strokes of undetermined source: the case for a new clinical construct
2014 Standout
Role of C-Reactive Protein at Sites of Inflammation and Infection
2018 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Thrombolysis for acute deep vein thrombosis
2004
Thrombolysis vs Heparin in the Treatment of Pulmonary Embolism
2002
Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)
1999 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
Thrombolytic therapy of pulmonary embolism
2002
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Thrombolytic therapy for pulmonary embolism
2009
Executive Summary
2012 Standout
Thrombolytic Therapy for Acute Pulmonary Embolism
2009
Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer
2002 Standout
Streptokinase vs alteplase in massive pulmonary embolism: A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction
1997
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Prevention of Venous Thromboembolism
2004 Standout
Thrombolytic Therapy: Current Status
1988
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Major Pulmonary Embolism
2002
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*
2006 Standout
Prevention of Venous Thromboembolism
2008 Standout
Low molecular weight heparin versus oral anticoagulants in the long-term treatment of deep venous thrombosis
2001
Iliofemoral Deep Venous Thrombosis: Safety and Efficacy Outcome during 5 Years of Catheter-directed Thrombolytic Therapy
1997
Thrombolytic Therapy in Unstable Patients with Acute Pulmonary Embolism: Saves Lives but Underused
2012
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Thrombolytic therapy of acute pulmonary embolism: Current status and future potential
1987
Novel management strategy for patients with suspected pulmonary embolism
2003
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
Heparin plus Alteplase Compared with Heparin Alone in Patients with Submassive Pulmonary Embolism
2002 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2004 Standout
Comparative Efficacy of a Two-Hour Regimen of Streptokinase Versus Alteplase in Acute Massive Pulmonary Embolism: Immediate Clinical and Hemodynamic Outcome and One-Year Follow-Up 11This study was partly supported by grants from Programme Hospitalier de la Recherche Clinique (Ministère de la Santé Publique), Paris; Boehringer Ingelheim, Reims Cedex, France; and Hoechst France, Puteaux, France.
1998
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Streptokinase or Heparin in the Treatment of Deep Vein Thrombosis
1982
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary Embolism
2004
Long-Term Results of Local Thrombolysis Followed by First Rib Resection: An Encouraging Clinical Experience in Treatment of Subclavian Vein Thrombosis
2000
Thrombolysis for acute deep vein thrombosis
2016
Streptokinase of heparin in the treatment of deep vein thrombosis. Follow-up results of a prospective study.
1982
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
Prolonged thromboprophylaxis following hip replacement surgery--results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin)
1997
Part 9: Post–Cardiac Arrest Care
2010 Standout
Antigenic, electrophoretic and binding alterations of human C-reactive protein modified selectively in the absence of calcium
1983
Pulmonary embolectomy for acute massive pulmonary embolism: an analysis of 71 cases.
1988
Thrombolytic therapy for treatment of acute pulmonary embolism
2016
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin.
1996
Randomized trial of subcutaneous low-molecular-weight heparin CY 216 (Fraxiparine) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism. A dose-ranging study.
1992
A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: An interim report of a prospective trial
1979
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Recurrence of pulmonary embolism during anticoagulant treatment: a prospective study.
1987
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
The Use of Thrombolytic Agents: Choice of Patient, Drug Administration, Laboratory Monitoring
1979
Low-Molecular-Weight Heparins
1997 Standout
Thrombectomy with temporary arteriovenous fistula: The treatment of choice in acute iliofemoral venous thrombosis
1984
Thrombectomy with temporary arteriovenous fistula: The treatment of choice in acute iliofemoral venous thrombosis
1984
Treatment of Venous Thromboembolism
1999
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
2013 Standout
THROMBOLYTIC THERAPY FOR VENOUS THROMBOEMBOLISM
1995
APC-resistance Is a Risk Factor for Postoperative Thromboembolism in Elective Replacement of the Hip or Knee – A Prospective Study
1999 StandoutNobel
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
The role of thrombolytic therapy in pulmonary embolism
2015
Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis
1984
Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage
2014
Sustained improvement of pulmonary hemodynamics in patients at rest and during exercise after thrombolytic treatment of massive pulmonary embolism.
1985
Works of B. Ly being referenced
Denaturation of Fibrinogen, the Protective Effect of Calcium
1972
A Prospective Study of Streptokinase and Heparin in the Treatment of Deep Vein Thrombosis
1978
A Controlled Clinical Trial of Streptokinase and Heparin in the Treatment of Major Pulmonary Embolism
1978